News

The U.S. Food and Drug Administration (FDA) has authorized a new drug that may help prevent COVID-19. It is called Evusheld (tixagevimab co-packaged with cilgavimab).1-3 Evusheld is not authorized for...

The American Cancer Society (ACS) has released its 2021 report on cancer, called Cancer Facts and Figures 2021. The data in this report is 2 to 4 years behind the...

As the coronavirus and flu season collide, this upcoming fall and winter will be like none the world has ever seen. Here in the United States, it is important to...

Editor’s Note: This article was first published on August 20, 2020. Further developments in what we know about the coronavirus are continuously emerging. Learn more in Advanced Breast Cancer and...

Even after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for...

Many of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments...

Our world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people...

The spread of the novel coronavirus, COVID-19, has changed our daily lives. But people with a higher risk for illness from COVID-19 are wondering what they can do to stay...

On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given...

With all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to...

For those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can...

The American Cancer Society (ACS) recently released its report, Cancer Statistics, 2020. The report found that the death rate from cancer in the US is dropping. Between 1991 and 2017...

The United States Food and Drug Administration (US FDA) approved Nerlynx (neratinib) for the treatment of metastatic breast cancer. Nerlynx is used in combination with the chemotherapy drug capecitabine. Specifically...

Last month, the FDA approved Kanjinti, the 5th biosimilar to Herceptin. Kanjinti is approved for the treatment of HER2-overexpressing adjuvant and metastatic breast cancer. Kanjinti is a HER2 receptor antagonist...